James Treace to retire from board; CEO John Treace appointed chairman effective May 20, 2025

TREACE MEDICAL CONCEPTS, INC.

James T. Treace to retire from board at 2025 annual meeting (expected May 20, 2025); departure not related to any disagreement.
Board appoints CEO & Founder John T. Treace as Chairman, effective immediately after the 2025 annual meeting.
Board size decreases from nine to eight directors upon James Treace's retirement.
Lead independent director Richard W. Mott will continue in his role.
No change in John T. Treace's compensation in connection with appointment.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

John T. Treace

Chairman of the Board

TMCI · TREACE MEDICAL CONCEPTS, INC.

Filed: April 7, 2025, 7:59 PM ET

appoint John T. Treace to serve as Chairman of the Board, effective upon the expiration of James T. Treace’s current term at the Company’s 2025 Annual Meeting.

Departed

James T. Treace

Director

TMCI · TREACE MEDICAL CONCEPTS, INC.

Filed: April 7, 2025, 7:59 PM ET

his intent to retire from the Board at the expiration of his current term at the 2025 annual meeting of stockholders

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John T. Treace was appointed as Chairman of the Board at TREACE MEDICAL CONCEPTS, INC..

Action: appointed
Role: Chairman of the Board

Exact text from the filing

appoint John T. Treace to serve as Chairman of the Board, effective upon the expiration of James T. Treace’s current term at the Company’s 2025 Annual Meeting.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

James T. Treace retired as Director at TREACE MEDICAL CONCEPTS, INC..

Action: retired
Role: Director

Exact text from the filing

his intent to retire from the Board at the expiration of his current term at the 2025 annual meeting of stockholders

View on SEC.gov

TREACE MEDICAL CONCEPTS, INC. filing history →

Source: SEC EDGAR

accession 0000950170-25-051362

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.